Identified by the cell surface marker CD44+ and the ability to form non-adherent spherical colonies in serum-free media and tumours when implanted into immunocompromised mice, CD44+ gastric CSCs represent ~0.6%–2.2% of the tumour cell population [169]. Here, CD44 is linked to neoplasm.